Valuation: Asahi Kasei Corporation

Market Cap 1,988B 12.56B 11.26B 10.29B 9.39B 17.7B 1,180B 18.26B 124B 49.46B 630B 47.13B 46.12B P/E 2027 *
11.5x
P/E 2028 * 10.7x
Enterprise Value 2,654B 16.76B 15.03B 13.74B 12.54B 23.63B 1,576B 24.37B 166B 66.03B 841B 62.91B 61.56B EV / Sales 2027 *
0.79x
EV / Sales 2028 * 0.77x
Free-Float
95.42%
Yield 2027 *
3.07%
Yield 2028 * 3.4%
11-04 Asahi Kasei Posts Higher Fiscal H1 Attributable Income; Revenue Up MT
11-04 Asahi Kasei Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027 CI
11-04 Asahi Kasei Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending March 31, 2027, Payable on December 1, 2026; Revises Dividend Guidance for the Full Fiscal Year Ending March 31, 2027 CI
11-04 Asahi Kasei Corporation Reports Earnings Results for the Half Year Ended September 30, 2026 CI
11-04 Asahi Kasei Signs Memorandum of Understanding with Power to Hydrogen to Accelerate Commercialization of Anion Exchange Membrane Water Electrolysis for Clean Hydrogen Production CI
10-23 Asahi Kasei Pins Its Growth on Electronic Materials Zonebourse
10-10 Asahi Kasei Therapeutics, Inc. Announces FDA Approval Of HOVILPRI Tablets Developed By AiCuris Anti-Infective Cures AG For Mucocutaneous HSV Lesions Refractory To Standard Antiviral Treatment In Immunocompromised Adults CI
10-09 US FDA approves Asahi Kasei's drug for persistent herpes infections RE
10-09 Japan's Nikkei limps to weekly loss as AI doubts, bond stress weigh RE
10-08 Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant Recipients CI
10-01 Teijin Frontier, Asahi Kasei Advance Merge to Form TA Frontier MT
09-30 Teijin Frontier Co., Ltd. concluded a basic agreement to acquire Asahi Kasei Advance Corporation from Asahi Kasei Corporation. CI
09-15 Asahi Kasei Bioprocess Unveils Vantij Su-Vfc Benchtop for Automated Single-Use Virus Filtration CI
1 day-7.16%
1 week-7.11%
Current month-7.11%
1 month-10.43%
3 months-11.91%
6 months-3.56%
Current year+7.31%
1 week 1,474
Extreme 1474
1,660
1 month 1,474
Extreme 1474
1,660
Current year 1,415
Extreme 1415
1,906
1 year 1,247
Extreme 1247
1,906
3 years 880
Extreme 880
1,906
5 years 880
Extreme 880
1,906
10 years 606.1
Extreme 606.1
1,906
Manager TitleAgeSince
Director of Finance/CFO - -
President 67 2022-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 2022-03-31
Director/Board Member 79 2018-05-31
Director/Board Member 67 2021-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-7.16%-7.11%+17.50%+49.86% 12.56B
-6.69%-10.96%+17.29%+9.50% 60.91B
-3.23%+1.53%+27.66%+24.85% 52.1B
+1.63%+8.03%+8.54%+29.52% 17.11B
-3.01%-2.15%+33.81%-11.72% 9.96B
-2.82%-14.67%+120.67%+7.93% 9.46B
-2.91%+0.33%+10.20% - 8.72B
-4.06%-14.23%+20.44%+4.09% 8.61B
+0.04%+6.02%-14.26%+6.25% 7.84B
-7.22%-13.33%+32.56%+7.64% 5.7B
Average -3.54%-4.65%+27.44%+14.21% 19.3B
Weighted average by Cap. -4.12%-4.40%+24.24%+16.77%

Financials

2027 *2028 *
Net sales 3,377B 21.33B 19.13B 17.48B 15.96B 30.07B 2,005B 31.02B 211B 84.03B 1,070B 80.06B 78.34B 3,390B 21.41B 19.2B 17.55B 16.02B 30.19B 2,013B 31.14B 212B 84.36B 1,074B 80.37B 78.65B
Net income 179B 1.13B 1.01B 925M 845M 1.59B 106B 1.64B 11.15B 4.45B 56.62B 4.24B 4.15B 186B 1.18B 1.05B 964M 880M 1.66B 111B 1.71B 11.61B 4.63B 58.96B 4.41B 4.32B
Net Debt 666B 4.21B 3.77B 3.45B 3.15B 5.93B 395B 6.12B 41.55B 16.57B 211B 15.78B 15.45B 606B 3.83B 3.44B 3.14B 2.87B 5.4B 360B 5.57B 37.84B 15.09B 192B 14.38B 14.07B
Projected Income Statement - Annual - Asahi Kasei Corporation
Logo Asahi Kasei Corporation
Asahi Kasei Corp is a Japan-based company mainly engaged in the materials business, housing business and healthcare business. The Company operates through three business segments. The Materials segment provides styrene monomer, acrylonitrile, polyethylene, automotive-related fibers, electronic materials, mixed signal large scale integrated circuits (LSI), hall elements, deep ultraviolet light-emitting diodes (LEDs), pharmaceutical and food additives and others. The Housing segment provides construction contracting, renovation and other housing-related business, as well as lightweight aerated concrete (ALC), insulation materials and others. The Healthcare segment provides medical drugs, hemodialysis and apheresis related equipment, virus removal filters, cardiopulmonary resuscitation-related products and others. The Company also provides plant engineering, environmental engineering, various research and information provision businesses, and personnel dispatch and introduction services.
Employees
47,895
Date Price Change Volume
26-11-06 JP¥1,490.50 -7.16% 8,301,200
26-11-05 JP¥1,605.50 +1.87% 12,032,600
26-11-04 JP¥1,576.00 -0.22% 5,369,100
26-11-02 JP¥1,579.50 -1.56% 4,151,800
26-10-30 JP¥1,604.50 -0.53% 4,008,000
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Asahi Kasei Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,490.50JPY
Average target price
1,981.67JPY
Spread / Average Target
+32.95%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Asahi Kasei Corporation
  1. Stock Market
  2. Stocks
  3. 3407 Stock